Correlation Between Sartorius Stedim and UPDATE SOFTWARE

Can any of the company-specific risk be diversified away by investing in both Sartorius Stedim and UPDATE SOFTWARE at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sartorius Stedim and UPDATE SOFTWARE into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Sartorius Stedim Biotech and UPDATE SOFTWARE, you can compare the effects of market volatilities on Sartorius Stedim and UPDATE SOFTWARE and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sartorius Stedim with a short position of UPDATE SOFTWARE. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sartorius Stedim and UPDATE SOFTWARE.

Diversification Opportunities for Sartorius Stedim and UPDATE SOFTWARE

-0.41

Correlation Coefficient

Sartorius Stedim  UPDATE SOFTWARE

Very good diversification

The 3 months correlation between Sartorius and UPDATE is -0.41. Overlapping area represents the amount of risk that can be diversified away by holding Sartorius Stedim Biotech and UPDATE SOFTWARE in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on UPDATE SOFTWARE and Sartorius Stedim is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sartorius Stedim Biotech are associated (or correlated) with UPDATE SOFTWARE. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of UPDATE SOFTWARE has no effect on the direction of Sartorius Stedim i.e., Sartorius Stedim and UPDATE SOFTWARE go up and down completely randomly.

Pair Corralation between Sartorius Stedim and UPDATE SOFTWARE

Assuming the 90 days trading horizon Sartorius Stedim Biotech is expected to generate 0.73 times more return on investment than UPDATE SOFTWARE. However, Sartorius Stedim Biotech is 1.37 times less risky than UPDATE SOFTWARE. It trades about 0.37 of its potential returns per unit of risk. UPDATE SOFTWARE is currently generating about -0.08 per unit of risk. If you would invest  18,215  in Sartorius Stedim Biotech on October 27, 2024 and sell it today you would earn a total of  2,515  from holding Sartorius Stedim Biotech or generate 13.81% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Sartorius Stedim Biotech  vs.  UPDATE SOFTWARE

Sartorius Stedim Biotech

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Sartorius Stedim Biotech are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Sartorius Stedim may actually be approaching a critical reversion point that can send shares even higher in February 2025.

UPDATE SOFTWARE

Risk-Adjusted Performance

14 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in UPDATE SOFTWARE are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady basic indicators, UPDATE SOFTWARE exhibited solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Sartorius Stedim and UPDATE SOFTWARE

The main advantage of trading using opposite Sartorius Stedim and UPDATE SOFTWARE positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sartorius Stedim position performs unexpectedly, UPDATE SOFTWARE can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in UPDATE SOFTWARE will offset losses from the drop in UPDATE SOFTWARE's long position.

The idea behind Sartorius Stedim Biotech and UPDATE SOFTWARE pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.